Navigation Links
MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems
Date:3/29/2011

WALTHAM, Mass., March 29, 2011 /PRNewswire/ -- MicroCHIPS, Inc., a developer of innovative drug delivery devices and biosensors, today announced that the U.S. Patent Office and Trademark Office has granted U.S. Patent No. 7,892,221, Method of Controlled Drug Delivery from Implant Device. This patent in conjunction with U.S. Patent No. 7,070,590 provides broad coverage for the design and fabrication of reservoir-based medical devices used for implantable drug delivery systems.

MicroCHIPS' intellectual property originated as patent filings at the Massachusetts Institute of Technology, by professors and MicroCHIPS cofounders Robert Langer and Michael Cima, and cofounder John Santini. These patents are licensed to MicroCHIPS, which has continued to develop and enhance the reservoir-based technology and to generate additional intellectual property covering microreservoirs, controlled release components and systems, and biosensors. As a result, MicroCHIPS' current patent portfolio includes more than 80 patents and more than 50 pending applications, covering the U.S., Canada, various countries in Europe and Asia, as well as Australia.

"The granting of this patent provides the fundamental building blocks for programmable medical drug delivery implants to address various diseases such as diabetes, osteoporosis, heart disease, and cancer," said Robert Langer, ScD, Institute Professor at the David H. Koch Institute for Integrative Cancer Research at MIT.

MicroCHIPS' miniaturized systems are adaptable to implants and catheters as well as on-body delivery systems, external pumps, pens and infusion systems. Currently, the MicroCHIPS technology is embodied in the company's medical implants that are part of a clinical trial to treat osteoporosis in women. The trial is evaluating the pharmacokinetics of precise delivery of human parathyroid hormone (hPTH 1-34) from a programmable, wireless implanted device.

"This patent and technology portfolio combin
'/>"/>

SOURCE MicroCHIPS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum
2. MEDRAD® Announces New Head of Interventional Business
3. Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective
4. WaferGen Announces Data Presentations From Newly Launched High-Throughput SmartChip Human microRNA Panel V2 at Scientific Conferences, Including AACR
5. Boston Scientific Announces Its ACC 2011 Schedule
6. Tris Pharma Announces Availability of the MyKidz® Iron Product Line - the Best Tasting Iron Supplements
7. Dendreon Announces Webcast Presentations at Upcoming Conferences
8. Diversified Medical Equipment & Supplies Corporation Announces New Home Care Medical Supply Division
9. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
10. JHP Pharmaceuticals Announces Multi-Year Contract Manufacturing Agreement
11. Ascension Orthopedics Announces Market Release of TITAN™ Modular Shoulder Fracture Prosthesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... Bolder BioTechnology, Inc. today announced that it has ... (SBIR) grant totaling $600,000 from the National Institute of ... of Health (NIH).  The grant will be used to ... analog to accelerate platelet recovery and improve survival in ...
... Technologies Foster Better Informed Consumers, Greater Interest in Personal... -- PHILADELPHIA, Pennsylvania, August 18, 2010 ... ... lpUnit=,PRN,; --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
Cached Medicine Technology:Bolder BioTechnology Announces $600,000 Grant from NIH to Study Long-Acting IL-11 Analog in Treating Acute Radiation Syndrome 2Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care 2Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care 3Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care 4Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care 5Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care 6Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care 7Advanced Web-Based Medical Technologies Foster Better Informed Consumers, Greater Interest in Personal Health Care 8
(Date:4/17/2014)... the first genetic variant specifically associated with the ... around 10-15 per cent of all breast cancer ... breast cancer sub-type, called invasive lobular carcinoma, gives ... this particular kind of breast cancer, which can ... today (Thursday) in the journal PloS Genetics ...
(Date:4/17/2014)... April issue of Experimental Biology and Medicine ... Rex Gaskins and Paul Kenis in the Institute ... the University of Illinois Urbana-Champaign describe their recent ... underlie a variety of cell functions including energy ... crucial roles in regulating normal cellular behavior, redox ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... It,s estimated that as many as 10 million older ... of loneliness and isolation. , However, new research ... retired older Americans for six years found that ... of depression by more than 30 percent. , "That,s ... State University professor of telecommunication, information studies and media ...
(Date:4/17/2014)... from Boston University School of Medicine (BUSM) have ... consumption in an experimental model. The findings, reported ... Alcohol Abuse , may lead to more effective ... is one of the leading causes of illness ... negative economic impact by limiting the productivity of ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... damage to DNA, study says , , THURSDAY, Dec. ... at risk of DNA damage from prolonged exposure to ... 83 airline pilots to 50 university faculty members from ... participants were analyzed for DNA abnormalities, specifically the number ...
... teens is slowing, survey finds , , THURSDAY, Dec. 11 (HealthDay ... teens, the abuse of painkillers such as Vicodin and Oxycontin ... in the use of drugs such as marijuana has stalled ... Institute on Drug Abuse says in its report, Monitoring ...
... The American Academy of Orthopaedic Surgeons (AAOS) has ... of Osteoarthritis of the Knee". These guidelines were explicitly ... knee replacement surgery. While a wide range of treatment ... patients after discussions with their physicians. , ...
... Growth Equities, Ltd. initiates coverage of PolyMedix Inc. (OTC ... $9.00 price target. PolyMedix focuses on developing novel ... The Company,s leading clinical development programs include the ... , , Emerging Growth ...
... President & CEO , , ... a drug delivery technology company, today announced that George DeMott, chairman ... position as chairman, effective immediately. Mr. DeMott will continue to ... , , The board of directors ...
... serious risk of a long-term hospital stay, and ventilator-associated ... 15% of all people who are ventilated, is among ... a higher resistance to antibiotics, patients who rely on ... as 26,000 Americans do every year. , Thanks to ...
Cached Medicine News:Health News:Pilots May Face Greater Cancer Risk 2Health News:10% of U.S. High School Seniors Use Vicodin 2Health News:10% of U.S. High School Seniors Use Vicodin 3Health News:AAOS Issues New Clinical Practice Guideline for Osteoarthritis of the Knee 2Health News:AAOS Issues New Clinical Practice Guideline for Osteoarthritis of the Knee 3Health News:Emerging Growth Equities, Ltd. Initiates Coverage of PolyMedix Inc. With a Buy Rating and a $9.00 Price Target 2Health News:DelSite Chairman George DeMott Resigns 2Health News:DelSite Chairman George DeMott Resigns 3Health News:There's a life-saving medical device sitting on your sink 2
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
... GYNECARE TVT is a minimally invasive, ... of stress urinary incontinence. GYNECARE TVT is ... of the urethra, and when needed, TVT ... the correct position. The procedure takes approximately ...
...
...
Medicine Products: